Search clinical trials for: Pneumococcal 13-valent Conjugate Vaccine (PCV13)

Total 531 results

Murdoch Childrens Research Institute
National Health and Medical Research Council, Australia; GlaxoSmithKline; Bill... and other collaborators

Completed

Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam

Pneumococcal Vaccines

Vietnam
Sinovac Life Sciences Co., Ltd.

Recruiting

Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Pneumococcal Infections

China
London School of Hygiene and Tropical Medicine
University College, London; Bill and Melinda Gates Foundation; Wellcome Trust; KEMRI-Wellcome... and other collaborators

Active, not recruiting

The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants (FPCV)

Pneumococcal Infection | Streptococcus Pneumoniae Infection | Invasive Pneumococcal Disease, Protection Against

Kenya
University of Witwatersrand, South Africa
University College, London

Completed

Reduced PCV Dosing Schedules in South African Infants (PCV1+1)

Pneumonia | Meningitis

South Africa
St. Antonius Hospital

Completed

Community Acquired Pneumonia: Outcome, Quality of Life and Immune Status (CAPolista)

Pneumonia | Immune Response | Streptococcus Pneumoniae

Netherlands
CanSino Biologics Inc.
Henan Center for Disease Control and Prevention

Completed

Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)

Pneumococcal Infections | Bacterial Infections | Streptococcal Infections

China
Telethon Kids Institute
Papua New Guinea Institute of Medical Research

Completed

PCV13 in Non-pregnant Papua New Guinean Women

Pneumococcal Infections

Papua New Guinea
Medical University of South Carolina

Completed

Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults

Aging | HIV Lipodystrophy

United States
University of Toledo Health Science Campus
National Institute on Aging (NIA)

Completed

Pneumonia Vaccine in Aging HIV Positive Individuals

Pneumococcal Infection

United States
Pfizer

Completed

A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China

Pneumococcal Infection

China
University of Oxford
University of Southampton; University of Bristol; University of London

Completed

13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study

Pneumococcal Disease

United Kingdom
Region Skane

Completed

Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease (IPS-BOOSTER)

Rheumatoid Arthritis | Systemic Vasculitis | Spondyloarthritis | Systemic Lupus | Sjögren Syndrome
Aghia Sophia Children's Hospital of Athens

Unknown

Immunological Memory Against Pneumococcus Induced by 3 Infant PCV 13 Vaccination Schedules

Immunogenicity, Vaccine | Immunologic Memory

Greece
Canadian Immunization Research Network

Completed

Vaccinating Children After Chemotherapy

Acute Lymphoblastic Leukemia

Canada
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Recruiting

Consistency, Immunogenicity, and Safety of Three Batches of 15-valent Pneumococcal Conjugate Vaccine

Healthy Volunteers

China
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Not yet recruiting

Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers

Pneumonia, Pneumococcal

China
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea

Pneumococcal Vaccine

Korea, Republic of
University of Oxford

Completed

Protection Against Pneumococcal Infection in Children With T1DM (T1DM)

Type 1 Diabetes Mellitus

United Kingdom
CanSino Biologics Inc.
Henan Center for Disease Control and Prevention

Completed

Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)

Pneumococcal Infections | Bacterial Infections | Streptococcal Infections

China
VA Office of Research and Development

Terminated

Pneumococcal Conjugate Vaccine in Aging Renal Transplant

Aging | Renal Transplantation

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.

Vaccines, Pneumococcal

Germany
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033)

Pneumococcal Infections

Japan
Pfizer

Completed

Safety and Immunogenicity of 20vPnC in Toddlers With 2 Prior Doses of Prevenar 13

Pneumococcal Disease

Spain, Poland, Hungary
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Vaccines, Pneumococcal

Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants

Vaccines, Pneumococcal

Italy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.

Vaccines, Pneumococcal

Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants

Vaccines, Pneumococcal

Poland
Walvax Biotechnology Co., Ltd.

Completed

Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old)

Diseases Caused by Streptococcus Pneumoniae Serotypes
Pfizer

Active, not recruiting

A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan

Pneumococcal Disease

Taiwan, India
Pfizer

Completed

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants

Pneumococcal Disease

Denmark, Belgium, Australia, Poland, Norway, Finland, Netherlands, Italy, Czechia, Estonia, Russian Federation, Slovakia
Pfizer

Completed

20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants

Pneumococcal Disease

Spain, United States, Canada, Chile, Greece, Germany, Finland, Argentina, Czechia, Hungary, Puerto Rico
Pfizer

Completed

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants

Pneumococcal Disease

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in India

Pneumococcal Infections

India
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants

Vaccines, Pneumococcal

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS

Pneumococcal Vaccines

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Pneumococcal Vaccine in Healthy Infants

Pneumococcal Infections | Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil

Vaccines, Pneumococcal Conjugate Vaccine

Brazil
Pfizer

Completed

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants

Pneumococcal Disease

United States, Puerto Rico
University of Oxford

Completed

An Alternative Booster Vaccine Against Meningitis and Ear Infections

Invasive Streptococcus Pneumoniae Disease

United Kingdom
Klara M. Pósfay Barbe
Swiss IBD Cohort Study

Completed

Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease (PCV13inSIBDCS)

Inflammatory Bowel Diseases | Crohn Disease | Colitis, Ulcerative

Switzerland
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-028)

Pneumococcal Infections

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan

Vaccines | Pneumococcal Conjugate Vaccine

Taiwan
Pfizer

Completed

Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization

Pneumococcal Infections

Israel
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

Vaccines, Pneumococcal Conjugate Vaccine

Canada
VA Sierra Nevada Health Care System
Merck Sharp & Dohme LLC

Not yet recruiting

Evaluation of PCV15 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans

Immunosuppression | Pneumococcal Vaccines
Pfizer

Completed

Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults

Pneumococcal Infections

United States
Pfizer

Completed

Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine

Vaccines, Pneumococcal

United States
PATH

Completed

Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants

Pneumococcal Disease

Gambia
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024) (PNEU-PLAN)

Pneumococcal Infections

Finland, Malaysia, Poland, Russian Federation, Thailand
Pfizer

Completed

A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older

Pneumococcal Vaccines | Pneumococcal Conjugate Vaccine

Japan

Search clinical trials for: Pneumococcal 13-valent Conjugate Vaccine (PCV13)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations